Reply to Rajchgot et al.: Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1105-1106. doi: 10.1164/rccm.201806-1116LE.

Authors

Carlo Vancheri¹, Michael Kreuter², Luca Richeldi³, Manuel Quaresma⁴, Susanne Stowasser⁴, Wim A Wuyts⁵

Affiliations

¹ 1 University of Catania Catania, Italy.
² 2 University of Heidelberg Heidelberg, Germany.
³ 3 Fondazione Policlinico A. Gemelli Rome, Italy.
⁴ 4 Boehringer Ingelheim International GmbH Ingelheim am Rhein, Germany and.
⁵ 5 University Hospitals Leuven Leuven, Belgium.

PMID: 30025211
DOI: 10.1164/rccm.201806-1116LE

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Idiopathic Pulmonary Fibrosis*
Indoles
Pyridones

Substances

Indoles
Pyridones
pirfenidone
nintedanib